BALTIMORE (PRWEB)
April 18, 2022
Ideal Option, a national leader in outpatient medication-assisted treatment for addiction to opioids, cocaine, methamphetamine, alcohol and other substances, has released its 2021 Annual Report of outcomes for patients living in Maryland.
This report contains an aggregated view of patients’ geographic and demographic characteristics, their stage and duration of care, adherence to medication, and their substance use over time based on lab specimens regularly collected during 2021 from more than 900 patients.
The data support the effectiveness of treating addiction with FDA-approved medications combined with regular lab testing to verify medication adherence, create accountability, and ensure patient safety.
Among Maryland patients who remained in treatment from initiation to the maintenance stage of care during 2021, the report shows:
-
95% less total opioid use - 98% less fentanyl use
- 95% less heroin use
- 94% less cocaine use
- 70% less methamphetamine use
- 84% less benzodiazepine use
The report also reveals an escalation in synthetic drug use in 2021 among enrolling patients, particularly fentanyl. Fentanyl positive rates at enrollment were up by 7% displacing heroin positive rates which were down by 42% compared to 2020. In addition, 39% of patients tested positive for multiple substances at enrollment, most commonly cocaine and opioids.
This data corroborates state reports of most fatal overdoses involving the simultaneous use of more than one substance. According to the Office of the Chief Medical Examiner and the Vital Statistics Administration (VSA) of the Maryland Department of Health, of the 757 fatal overdoses involving cocaine that occurred during the third quarter year-to-date (YTD) in 2021, 685 were mixed with opioids.
“Although no FDA-approved medications exist for treating isolated stimulant use disorder, Ideal Option’s data reveals that buprenorphine is highly effective for reducing cocaine and methamphetamine use among people using both opioids and stimulants,” said Tim Kilgallon, CEO at Ideal Option.
View the full Ideal Option 2021 Annual Patient Outcomes Report for Maryland here: [https://www.idealoption.com/patient-outcomes.
Ideal Option has helped more than 50,000 patients through a network of over 75 outpatient clinics across 10 states: Alaska, Arkansas, Idaho, Maryland, Minnesota, Montana, New Mexico, North Dakota, Oregon and Washington.
With no waitlists and most forms of insurance accepted, including Medicare and Medicaid, patients can typically get started on treatment for fentanyl, heroin, stimulants, alcohol, or other substances within 1-3 business days.
Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.
About Ideal Option
Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 50,000 patients through a network of 75 office-based medication-assisted treatment (MAT) clinics across 10 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.
Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.
In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.
Share article on social media or email: